These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 26635153)

  • 1. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
    Thompson FD; Joekes AM; Hussein MM
    Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():129S-33S. PubMed ID: 26635153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
    Thompson FD; Joekes AM; Hussein MM
    Br J Clin Pharmacol; 1979; 8(Suppl 2):129S-133S. PubMed ID: 526392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
    Pedersen EB; Larsen JS
    Postgrad Med J; 1980; 56 Suppl 2():27-32. PubMed ID: 7433339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment of hypertension with labetalol.
    Prichard BN; Boakes AJ; Hernández R
    Br J Clin Pharmacol; 1979; 8(Suppl 2):171S-177S. PubMed ID: 526398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of hypertension with labetalol.
    Prichard BN; Boakes AJ; Hernandez R
    Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():171S-7S. PubMed ID: 26635162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.
    Joekes AM; Thompson FD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):789-93. PubMed ID: 990156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labetalol in severe and resistant hypertension.
    Williams LC; Murphy MJ; Parsons V
    Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():143S-7S. PubMed ID: 26635156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labetalol in severe and resistant hypertension.
    Williams LC; Murphy MJ; Parsons V
    Br J Clin Pharmacol; 1979; 8(Suppl 2):143S-147S. PubMed ID: 526395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of labetalol in hypertension during exercise and postural changes.
    Balasubramanian V; Mann S; Millar-Craig MW; Raftery EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):95S-100S. PubMed ID: 526410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of labetalol in elderly and young hypertensive patients following single and multiple doses.
    Rocci ML; Vlasses PH; Cressman MD; Sirgo MA; Plachetka JR
    Pharmacotherapy; 1990; 10(2):92-9. PubMed ID: 2349138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dose-ranging study of labetalol in moderate to moderately severe hypertension.
    Darmansjah I; Setiawati A; Prabowo P; Sukandar E; Parsoedi I; Ardaya ; Bahry B; Jusman J; Anggraeni E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):226-31. PubMed ID: 7620693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
    Zech P; Pozet N; Sassard J; Vincent M
    Nouv Presse Med; 1980 Mar; 9(15):1087-90. PubMed ID: 7008020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous labetalol in hypertensive patients treated with beta-adrenoreceptor-blocking drugs.
    Pearson RM; Havard CW
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):795-8. PubMed ID: 10953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute management of severe hypertension with oral labetalol.
    Ghose RR
    Br J Clin Pharmacol; 1979; 8(Suppl 2):189S-193S. PubMed ID: 526400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labetalol in the treatment of angina pectoris.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):166-74. PubMed ID: 2881899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypotensive effect of a single daily dose of labetalol: a preliminary study.
    Rossi A; Ziacchi V; Lomanto B
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):438-45. PubMed ID: 6754634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of labetalol in hypertension during exercise and postural changes.
    Balasubramanian V; Mann S; Millar-Craig MW; Raftery EB
    Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():95S-100S. PubMed ID: 26635176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of treatments with labetalol and hydrochlorothiazide on ventilatory function of asthmatic hypertensive patients with demonstrated bronchosensitivity to propranolol.
    Falliers CJ; Vrchota J; Blasucci DJ; Maloy JW; Medakovic M
    J Clin Hypertens; 1985 Mar; 1(1):70-9. PubMed ID: 3836297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot trial of labetalol (AH 5158A): a combined alpha and beta blocker in treatment of hypertension.
    Dent R; Kellaway GS
    N Z Med J; 1977 Sep; 86(595):213-5. PubMed ID: 305013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labetalol in resistant hypertension.
    Dargie HJ; Dollery CT; Daniel J
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):751-5. PubMed ID: 990154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.